ICE Pharma
Tommaso Maino has a solid work experience in the financial and accounting field. Tommaso started their career at EY as an Assistant Staff in September 2017 and worked there until August 2019. Tommaso then progressed to the role of Audit Senior at EY from August 2019 to September 2020. After that, they joined Snam in September 2020, where they worked in Administration and Financial Statements until May 2022. Currently, they hold the position of Chief Accountant at ICE Pharma, starting from May 2022.
Tommaso Maino received a Laurea Magistrale LM in Economia e Legislazione di Impresa with a field of study in Governance controllo e revisione aziendale from Università di Pavia from 2015 to 2017. Prior to that, they obtained a Laurea Triennale in Amministrazione controllo e finanza aziendale from the same university from 2013 to 2015. In addition, Tommaso Maino holds a certification in EY Analytics - Information strategy - Bronze from EY, obtained in an unspecified year.
ICE Pharma
ICE Pharma is a multinational company providing products and services to the pharmaceutical and healthcare markets. Founded more than 70 years ago, the Company has a network of manufacturing facilities and subsidiaries in North and South America, Europe, Asia and Oceania. We commercialise our products and services in all the major global markets and serve customers in over 50 countries. We are a key supplier to the pharmaceutical industry providing a range of active pharmaceutical ingredients (APIs) including Ursodeoxycholic acid (UDCA) and Inosine Pranobex. We also supply excipients, cell culture media for diagnostics, GMP intermediates and research chemicals. Our services business provides contract manufacturing for solid and liquid finished dosage forms. We manufacture and commercialise branded products in the pharmaceutical, nutraceutical and cosmetics markets.